Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis

Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis

The preferred antithrombotic strategy for secondary prevention in patients with cryptogenic stroke (CS) and patent foramen ovale (PFO) is unknown. We pooled multiple observational studies and used propensity score-based methods to estimate the comparative effectiveness of oral anticoagulation (OAC)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: David M. Kent, Issa J Dahabreh, Robin Ruthazer, Anthony J. Furlan, Christian Weimar, Joaquı́n Serena, Bernhard Meier, Heinrich P. Mattle, Emanuele Di Angelantonio, Maurizio Paciaroni, Herwig Schuchlenz, Shunichi Homma, Jennifer S. Lutz, David E. Thaler
Formatua: Revisão
Hizkuntza:ingelesa
Argitaratua: 2015
Sarrera elektronikoa:https://doi.org/10.1093/eurheartj/ehv252
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

https://doi.org/10.1093/eurheartj/ehv252

Antzeko izenburuak